The $1.5 billion deal is due to close in early 2025.
Mubadala acquires KELIX bio
KELIX bio is a specialty pharmaceutical business.
Avalon sets sights on Tadawul listing
The firm will offer 6 million shares in its Initial Public Offering.
Pfizer Q1 profit at $5.5bn
Profit fell on declining COVID-19 vaccine revenues.
Menarini opens office in Dubai
The Italian pharma giant is looking at expansion in MENA.
